Arden Trust’s Bausch Health BHC Stock Holding History

Arden Trust’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,868	Closed	-$106K	–	365
2020 Q1	$106K	Buy	+6,868	New	+$166K	0.02%	374

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Arden Trust's BHC Position: Q2 2020 in Review

Arden Trust sold out of Bausch Health (BHC) in Q2 2020, closing a stake of 6,868 shares — an estimated $106K sold.

Arden Trust first reported a position in BHC in Q1 2020 and held it in 1 quarter. The position peaked at $106K in Q1 2020. 303 funds tracked by Wall St. Rank hold BHC as of Q2 2020.

Arden Trust reported no remaining Bausch Health position as of Q2 2020 after selling out during the quarter.
Arden Trust sold 6,868 Bausch Health shares in Q2 2020, an estimated $106K.
Arden Trust first reported a position in Bausch Health in Q1 2020 and held it in 1 quarter.
Arden Trust's Bausch Health position peaked at $106K in Q1 2020.
303 funds tracked by Wall St. Rank held Bausch Health as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.